Tinghong Ye

6.4k total citations · 2 hit papers
126 papers, 4.1k citations indexed

About

Tinghong Ye is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tinghong Ye has authored 126 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Molecular Biology, 26 papers in Oncology and 25 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tinghong Ye's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (19 papers), Liver Disease Diagnosis and Treatment (12 papers) and Immune cells in cancer (10 papers). Tinghong Ye is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (19 papers), Liver Disease Diagnosis and Treatment (12 papers) and Immune cells in cancer (10 papers). Tinghong Ye collaborates with scholars based in China, United States and Israel. Tinghong Ye's co-authors include Luoting Yu, Yuquan Wei, Yuqin Yao, Ningyu Wang, Yong Xia, Yongmei Xie, Cailing Gan, Hongyao Liu, Yongxia Zhu and Xuejiao Song and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and ACS Nano.

In The Last Decade

Tinghong Ye

124 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting fibrosis: mechanisms and clinical trials

2022 296 citations Manyu Zhao, Liqun Wang et al. profile →
Liver Fibrosis: Therapeutic Targets and Advances in Drug Therapy

2021 153 citations Zui Tan, Hongbao Sun et al. Frontiers in Cell and Developmental Biology profile →

Peers

Countries citing papers authored by Tinghong Ye

Since Specialization

Citations

This map shows the geographic impact of Tinghong Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tinghong Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tinghong Ye more than expected).

Fields of papers citing papers by Tinghong Ye

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tinghong Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tinghong Ye. The network helps show where Tinghong Ye may publish in the future.

Co-authorship network of co-authors of Tinghong Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Tinghong Ye. A scholar is included among the top collaborators of Tinghong Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tinghong Ye. Tinghong Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Design, synthesis, and evaluation of a novel TRAIL-activated HDAC6 inhibitor for the treatment of pulmonary fibrosis 2024 ·Bioorganic & Medicinal Chemistry ·Ying Gao, (unknown), (unknown), Hao Cui, Xuxi Chen, Liqun Wang, Manyu Zhao, (unknown), Ling Zhang, Tinghong Ye, Yong Zhu, Yuqin Yao	3
2	BRD4: an effective target for organ fibrosis 2024 ·Biomarker Research ·Qun Wei, Cailing Gan, Meng Sun, Yuting Xie, Hongyao Liu, Taixiong Xue, (unknown), Chunheng Mo, Tinghong Ye	9
3	Immunotherapy for gastric cancer: Advances and challenges 2024 ·SHILAP Revista de lepidopterología ·Pei Zhang, (unknown), (unknown), Chen Chang, Cailing Gan, Tinghong Ye, (unknown)	5
4	Tetrahedral Framework Nucleic Acids Delivery of Pirfenidone for Anti-Inflammatory and Antioxidative Effects to Treat Idiopathic Pulmonary Fibrosis 2024 ·ACS Nano ·Yuting Xie, Sirong Shi, (unknown), Xinyu Wang, Yue Lin, (unknown), Doudou Wang, Jing Han, Tinghong Ye, Yunfeng Lin	8
5	Niclosamide - encapsulated lipid nanoparticles for the reversal of pulmonary fibrosis 2024 ·Materials Today Bio ·Yan Yu, Hongyao Liu, Liping Yuan, Meng Pan, Zhongwu Bei, Tinghong Ye, Zhiyong Qian	8
6	A nonenzymatic electrochemical sensor for the detection of hydrogen peroxide in vitro and in vivo fibrosis models 2023 ·Chinese Chemical Letters ·Hongyao Liu, Yan Yu, Taixiong Xue, Cailing Gan, Yuting Xie, Doudou Wang, Peilin Li, Zhiyong Qian, Tinghong Ye	6
7	SLC31A1 Identifying a Novel Biomarker with Potential Prognostic and Immunotherapeutic Potential in Pan-Cancer 2023 ·Biomedicines ·Pei Zhang, (unknown), (unknown), Chen Chang, (unknown), (unknown), (unknown), Tinghong Ye, Dan Cao	10
8	Liver Fibrosis: Therapeutic Targets and Advances in Drug Therapy breakdown → 2021 ·Frontiers in Cell and Developmental Biology ·Zui Tan, Hongbao Sun, Taixiong Xue, Cailing Gan, Hongyao Liu, Yuting Xie, Yuqin Yao, Tinghong Ye	153
9	Epigenetic regulation in fibrosis progress 2021 ·Pharmacological Research ·Taixiong Xue, Xingyu Qiu, Hongyao Liu, Cailing Gan, Zui Tan, Yuting Xie, Di Wang, Tinghong Ye	73
10	Emerging targets and potential therapeutic agents in non-alcoholic fatty liver disease treatment 2020 ·European Journal of Medicinal Chemistry ·Yu Yang, Yu Zhao, Wenzhen Li, Yuyao Wu, (unknown), Yijie Wang, (unknown), Tinghong Ye, Yongmei Xie, Zhiqiang Cheng, Jun He, Peng Bai, Yiwen Zhang, Liang Ouyang	11
11	Repurposing of the anti-helminthic drug niclosamide to treat melanoma and pulmonary metastasis via the STAT3 signaling pathway 2019 ·Biochemical Pharmacology ·Yongxia Zhu, Weiqiong Zuo, Lijuan Chen, (unknown), (unknown), (unknown), Xiuli Wu, Hongyao Liu, (unknown), Wanglai Hu, Yuqi Guo, Yue Wang, Tinghong Ye	36
12	Comparison of Concanavalin a-Induced Murine Autoimmune Hepatitis Models 2018 ·Cellular Physiology and Biochemistry ·Tinghong Ye, Tingting Wang, Xiaoxue Yang, Xiaoli Fan, Maoyao Wen, Yi Shen, (unknown), Ruoting Men, Li Yang	53
13	An overview of Sirtuins as potential therapeutic target: Structure, function and modulators 2018 ·European Journal of Medicinal Chemistry ·Yijie Wang, Jun He, (unknown), Mingxing Hu, Wenzhen Li, (unknown), Xin Wang, Tinghong Ye, Yiwen Zhang, Liang Ouyang	156
14	Inhibition of Stat3 signaling pathway by nifuroxazide improves antitumor immunity and impairs colorectal carcinoma metastasis 2017 ·Cell Death and Disease ·Tinghong Ye, Fangfang Yang, Yongxia Zhu, Yali Li, Qian Lei, Xuejiao Song, Yong Xia, Ying Xiong, Lidan Zhang, Ningyu Wang, Lifeng Zhao, Hongfeng Gou, Yongmei Xie, Shengyong Yang, Luoting Yu, Li Yang, Yuquan Wei	76
15	Cryptotanshinone induces melanoma cancer cells apoptosis via ROS-mitochondrial apoptotic pathway and impairs cell migration and invasion 2016 ·Biomedicine & Pharmacotherapy ·Tinghong Ye, (unknown), Yongxia Zhu, Qiang Feng, Bing He, (unknown), Lifeng Zhao, Yiwen Zhang, Luoting Yu, Li Yang	51
16	Malignant Pleural Effusion and ascites Induce Epithelial-Mesenchymal Transition and Cancer Stem-like Cell Properties via the Vascular Endothelial Growth Factor (VEGF)/Phosphatidylinositol 3-Kinase (PI3K)/Akt/Mechanistic Target of Rapamycin (mTOR) Pathway 2016 ·Journal of Biological Chemistry ·Tao Yin, Guoping Wang, Sisi He, Guobo Shen, Chao Su, (unknown), Xiawei Wei, Tinghong Ye, Ling Li, Shengyong Yang, Dan Li, Fuchun Guo, Zeming Mo, Yang Wan, Ping Ai, Xiaojuan Zhou, Yantong Liu, Yongsheng Wang, Yuquan Wei	27
17	A novel small-molecule YLT256 inhibits proliferation and induces apoptosis both in vitro and in vivo in solid tumors 2016 ·Biomedicine & Pharmacotherapy ·Hongxia Deng, Jun Zeng, Yongxia Zhu, Tinghong Ye, Yong Xia, Yao Shi, Ningyu Wang, Lidan Zhang, Xuejiao Song, Weiqiong Zuo, Tiantao Gao, Luoting Yu	1
18	Lobaplatin arrests cell cycle progression, induces apoptosis and impairs migration and invasion in B16-F10 melanoma cell line in vitro 2014 ·Biomedicine & Pharmacotherapy ·Fangfang Yang, Yang Yu, Qian Lei, Anqi Zeng, Yali Li, Yongmei Xie, Tinghong Ye, Yuquan Wei	28
19	SKLB316, a novel small-molecule inhibitor of cell-cycle progression, induces G2/M phase arrest and apoptosis in vitro and inhibits tumor growth in vivo 2014 ·Cancer Letters ·Yong Xia, Qian Lei, Yongxia Zhu, Tinghong Ye, Ningyu Wang, Guo‐Bo Li, (unknown), Yantong Liu, Bin Shao, Tao Yin, (unknown), Wenshuang Wu, Xuejiao Song, Ying Xiong, Yuquan Wei, Luoting Yu	35
20	A Novel Benzothiazole Derivative YLT322 Induces Apoptosis via the Mitochondrial Apoptosis Pathway In Vitro with Anti-Tumor Activity in Solid Malignancies 2013 ·PLoS ONE ·Xuejiao Song, Yong Xia, (unknown), Lidan Zhang, (unknown), Youzhi Xu, Tinghong Ye, Yao Shi, (unknown), Luoting Yu	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact